| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cadrenal Therapeutics, Inc. (CVKD) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. CVKD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 128.6K | $383.2K | -4,778 | |
| Dir | 5.0K | $14.9K | - | |
| CFO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Pham Quang X49 | Chairman, CEO And Interim CFO | Sell | 4,126 | $3.18 | $13,110.42 | -1.6% | - | - | |
| Jun 2, 2026 | Pham Quang X49 | CEO And Chairman | Sell | 652 | $4.72 | $3,074.57 | -0.2% | - | - | |
| May 22, 2026 | Pham Quang X49 | CEO And Chairman | Sell | 1,165 | $5.69 | $6,628.85 | -0.6% | - | - | |
| Dec 29, 2025 | Szot Matthew K45 | Chief Financial Officer | Sell | 9,933 | $6.97 | $69,233.01 | -100% | -38.5% | - | |
| Oct 27, 2025 | Szot Matthew K45 | Chief Financial Officer | Sell | 3,600 | $13.99 | $50,364.00 | -14.2% | -41.2% | - | |
| Oct 27, 2025 | Pham Quang X49 | CEO And Chairman | Sell | 2,444 | $14.01 | $34,236.72 | -0.6% | -41.2% | - | |
| Oct 13, 2025 | Pham Quang X49 | CEO And Chairman | Sell | 3,600 | $14.09 | $50,706.00 | -0.9% | -39.0% | - | |
| Oct 13, 2025 | Szot Matthew K45 | Chief Financial Officer | Sell | 3,493 | $14.03 | $49,011.07 | -10.8% | -39.0% | - | |
| Oct 6, 2025 | Szot Matthew K45 | Chief Financial Officer | Sell | 107 | $13.99 | $1,496.93 | -0.6% | -45.9% | - | |
| Oct 2, 2025 | Pham Quang X49 | CEO And Chairman | Sell | 500 | $14.13 | $7,065.00 | -0.2% | -52.2% | - |